DE69814669D1 - Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten - Google Patents
Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor AntagonistenInfo
- Publication number
- DE69814669D1 DE69814669D1 DE69814669T DE69814669T DE69814669D1 DE 69814669 D1 DE69814669 D1 DE 69814669D1 DE 69814669 T DE69814669 T DE 69814669T DE 69814669 T DE69814669 T DE 69814669T DE 69814669 D1 DE69814669 D1 DE 69814669D1
- Authority
- DE
- Germany
- Prior art keywords
- ephedrine
- pharmaceutical composition
- composition containing
- ephedrin
- receptor antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KWGRBVOPPLSCSI-PSASIEDQSA-N (1s,2r)-2-(methylamino)-1-phenylpropan-1-ol Chemical compound CN[C@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-PSASIEDQSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000000938 histamine H1 antagonist Substances 0.000 title 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000150 Sympathomimetic Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940127230 sympathomimetic drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6557297P | 1997-11-14 | 1997-11-14 | |
| PCT/US1998/023479 WO1999025328A1 (en) | 1997-11-14 | 1998-11-04 | (+)-ephedrine as a sympathomimetic drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69814669D1 true DE69814669D1 (de) | 2003-06-18 |
| DE69814669T2 DE69814669T2 (de) | 2003-11-27 |
Family
ID=22063647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69814669T Expired - Fee Related DE69814669T2 (de) | 1997-11-14 | 1998-11-04 | Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1030659B1 (de) |
| AT (1) | ATE240097T1 (de) |
| AU (1) | AU1305999A (de) |
| DE (1) | DE69814669T2 (de) |
| DK (1) | DK1030659T3 (de) |
| ES (1) | ES2199474T3 (de) |
| PT (1) | PT1030659E (de) |
| WO (1) | WO1999025328A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1314199B1 (it) * | 1999-10-20 | 2002-12-06 | Ambros Pharma S R L | Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita' |
| DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
-
1998
- 1998-11-04 AT AT98956561T patent/ATE240097T1/de not_active IP Right Cessation
- 1998-11-04 WO PCT/US1998/023479 patent/WO1999025328A1/en active IP Right Grant
- 1998-11-04 DE DE69814669T patent/DE69814669T2/de not_active Expired - Fee Related
- 1998-11-04 AU AU13059/99A patent/AU1305999A/en not_active Abandoned
- 1998-11-04 PT PT98956561T patent/PT1030659E/pt unknown
- 1998-11-04 ES ES98956561T patent/ES2199474T3/es not_active Expired - Lifetime
- 1998-11-04 EP EP98956561A patent/EP1030659B1/de not_active Expired - Lifetime
- 1998-11-04 DK DK98956561T patent/DK1030659T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1030659T3 (da) | 2003-09-15 |
| DE69814669T2 (de) | 2003-11-27 |
| PT1030659E (pt) | 2003-09-30 |
| AU1305999A (en) | 1999-06-07 |
| EP1030659B1 (de) | 2003-05-14 |
| WO1999025328A1 (en) | 1999-05-27 |
| ES2199474T3 (es) | 2004-02-16 |
| ATE240097T1 (de) | 2003-05-15 |
| EP1030659A1 (de) | 2000-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20022784B (en) | Celecoxib Composition | |
| GR1002097B (en) | A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| GEP20002013B (en) | Therapeutical Means | |
| CA2260943A1 (en) | Formulation of 5-ht agonists | |
| NZ319531A (en) | An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist | |
| GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
| ATE311867T1 (de) | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen | |
| IL76932A (en) | Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen | |
| MXPA02007690A (es) | Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide. | |
| IL130714A0 (en) | Dosage forms and method for ameliorating male erectile dysfunction | |
| BR0012080A (pt) | Métodos e composições para administração intranasal de apomorfina | |
| FI972542A0 (fi) | Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten | |
| IL103303A (en) | Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain | |
| FR2735369B1 (fr) | Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside | |
| EP0663835A1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft. | |
| ES2189252T3 (es) | Composiciones analgesicas que comprenden un antagonista de la colecistoquinina y un opioide. | |
| PL348202A1 (en) | Pharmaceutically active composition and dispensing device | |
| AP2001002084A0 (en) | Orally administered controlled delivery system for once daily adminstration of ciprofloxacin | |
| GEP20043313B (en) | Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility | |
| MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
| ATE240097T1 (de) | Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten | |
| AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
| AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
| TR199800156T1 (xx) | �ok d���k dozlu ila�lar� kat� dozaj �ekillerinde haz�rlama prosesi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |